Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:50 PM
Ignite Modification Date:
2025-12-24 @ 5:50 PM
NCT ID:
NCT01568268
Eligibility Criteria:
Inclusion Criteria:
* 19 years and older, younger than 70 years old
* American society of Anesthesiologists physical status classification I to III
* those who undergo laparoscopic gynecologic, abdominal or other surgery under general anesthesia
* surgery for which anesthesia is expected to last at least 30 minutes
* if a subject has or may develop prolongation of cardiac conduction intervals, particularly corrected QT interval, he/she may be enrolled at the discretion of the investigator.
Exclusion Criteria:
* known hypersensitivity/ contraindication to 5-hydroxytryptamine antagonists or study drug excipient
* inability to understand or cooperate with the study procedures as determined by the investigator
* women who are pregnant, nursing or planning to become pregnant, are not using effective birth control, or that have had a positive serum pregnancy test within 7 days prior to surgery day 1.
* has received any investigational drug within 30 days before study entry
* having taken any drug with potential antiemetic efficacy within 24 hour prior to anesthetic procedures.
* any vomiting, retching, or nausea in the 24 hours preceding the administration of anesthesia
* known or suspected current history of alcohol abuse or drug abuse.
* any condition, which in the opinion of the investigator would make the subject ineligible for participation in the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Maximum Age:
70 Years
Study:
NCT01568268
Study Brief:
Protocol Section:
NCT01568268